Evidence profile · Growth Hormoneresearch use only
§Evidence profile · Growth Hormone
Tesamorelin
A GHRH analog with FDA-approved clinical indications and strong human data.
Evidence grade: Established
What Tesamorelin is
Tesamorelin stimulates endogenous growth hormone release and carries an approved clinical indication. It anchors the growth-hormone category with genuine human evidence.
Mechanism (preclinical)
Binds GHRH receptors on the pituitary, increasing pulsatile growth hormone secretion.
Primary research areas
GH/IGF-1 axisVisceral adipose tissueBody-composition endpoints
Selected studies
Visceral fat reduction (human RCT)
2010Statistically significant reduction vs. placebo.
Regulatory status
FDA-approved for a specific clinical indication. Prescription-only.
If you source Tesamorelin for laboratory research
Buy only from a vendor that publishes a lot-matched COA from an independent laboratory. Check the lot number on the vial against the certificate. Read the HPLC result and the mass spectrometry result. Ask for the chromatogram.